Quisinostat as a radiosensitizer for the treatment of glioblastoma
In this episode, Costanza Lo Cascio, Artak Tovmasyan, and Shwetal Mehta discuss the identification of a brain-penetrant HDAC inhibitor with radiosensitizing properties for the treatment of glioblastoma.
Видео Quisinostat as a radiosensitizer for the treatment of glioblastoma канала Journal of Clinical Investigation
Видео Quisinostat as a radiosensitizer for the treatment of glioblastoma канала Journal of Clinical Investigation
Показать
Комментарии отсутствуют
Информация о видео
22 ноября 2023 г. 22:00:42
00:05:43
Другие видео канала
JCI's Conversations with Giants in Medicine: Barbara Kahn
Increased cardiomyocyte proliferation benefit depends on the heart injury
Maintenance DNA methylation is essential for development and stability
iRHOM2 is a critical pathogenic mediator of inflammatory arthritis
JCI’s Conversations with Giants in Medicine: Katherine High
Microglial activation and tau transmission aggravated by Galectin-3 in tauopathy
JCI’s Conversations with Giants in Medicine: Lucy Shapiro
MicroRNA-21 inhibition reduces profibrotic factor release from platelets
Insight into helminth-associated susceptibility to tuberculosis
Kisspeptin receptor agonist and female reproductive disorders
JCI's Conversations with Giants in Medicine: Christine Seidman
Epigenetic targeting improves metabolic defects in obesity-prone mice
Calcium release in sweat glands
High-resolution atlas of the human kidney
Long noncoding RNAs and targetable kinases and glioblastoma radiation resistance
Protection against iatrogenically induced hearing loss
Secondary insult reveals etiology of GATA2 enhancer mutation-associated blood disorder
Synectin-mediated mechanisms in liver fibrosis
Immune checkpoint receptors for HBV infection
JCI's Conversations with Giants in Medicine: William Paul